Sethera Team
Karsten Eastman
CEODr. Eastman received a PhD from the University of Utah under the mentorship of Professor Vahe Bandarian, where they discovered the key processes that enable Sethera Therapeutics’ innovative technology.
As a co-founder of Sethera, Dr. Eastman is leading the company’s efforts to commercialize cutting-edge peptide therapeutics, drawing on their experience in enzyme and peptide research, patent development, and engagement with key business mentors.
Vahe Bandarian
CSO and PresidentProfessor Vahe Bandarian is a distinguished faculty member and Associate Dean at the University of Utah, recognized for his exceptional contributions to the field of chemistry. He is a Fellow of the American Chemical Society (ACS), the American Association for the Advancement of Science (AAAS), and the American Society for Biochemistry and Molecular Biology (ASBMB).
His groundbreaking research has earned him the prestigious Pfizer Award in Enzyme Chemistry from the ACS and the Distinguished Research Award from the University of Utah.
Dr. Lei Shi
Director of Protein Design and Enzyme Engineering
Dr. Basab Roy
Director of Biomanufacturing and Biological Development
Dr. Roberto Salatino
Lead Molecular Biology EngineerSethera Board
Ms. Cynthia Tsai
ChairVahe Bandarian
Karsten Eastman
General Larry V. Lunt
Scientific Advisory Board
